The melting pot of the MHC II peptidome

Current Opinion in Immunology

Volumn 40, Issue , 2016, Pages 70-77

  Stern, Lawrence J ^a   Santambrogio, Laura ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR IMMUNITY; ENDOSOME; IMMUNOLOGICAL TOLERANCE; MELTING POINT; PATHOGENESIS; ANIMAL; ANTIGEN PRESENTATION; ENDOCYTOSIS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; METABOLISM; T LYMPHOCYTE;

ANTIGEN; HLA ANTIGEN CLASS 2; PEPTIDE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; ENDOCYTOSIS; ENDOSOMES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; MASS SPECTROMETRY; PEPTIDES; T-LYMPHOCYTES;

EID: 84962233796     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2016.03.004     Document Type: Review

References (107)

1. Chicz R.M., Urban R.G., Lane W.S., Gorga J.C., Stern L.J., Vignali D.A., Strominger J.L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 1992, 358:764-768.
2. Hunt D.F., Michel H., Dickinson T.A., Shabanowitz J., Cox A.L., Sakaguchi K., Appella E., Grey H.M., Sette A. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science 1992, 256:1817-1820.
3. Rudensky A., Preston-Hurlburt P., Hong S.C., Barlow A., Janeway C.A. Sequence analysis of peptides bound to MHC class II molecules. Nature 1991, 353:622-627.
4. Mommen G.P., Marino F., Meiring H.D., Poelen M.C., van Gaans-van den Brink J.A., Mohammed S., Heck A.J., van Els C.A. Sampling from the proteome to the HLA-DR ligandome proceeds via high specificity. Mol Cell Proteomics 2016.
5. Bergseng E., Dorum S., Arntzen M.O., Nielsen M., Nygard S., Buus S., de Souza G.A., Sollid L.M. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires. Immunogenetics 2015, 67:73-84.
6. Sofron A., Ritz D., Neri D., Fugmann T. High-resolution analysis of the murine MHC class II immunopeptidome. Eur J Immunol 2016, 46:319-328.
7. Clement C.C., Becerra A., Yin L., Zolla V., Huang L., Merlin S., Follenzi A., Shaffer S.A., Stern L.J., Santambrogio L. The dendritic cell MHC II peptidome derives from a variety of processing pathways and includes peptides with a broad spectrum of HLA-DM sensitivity. J Biol Chem 2016.
8. Schellens I.M., Hoof I., Meiring H.D., Spijkers S.N., Poelen M.C., van Gaans-van den Brink J.A., van der Poel K., Costa A.I., van Els C.A., van Baarle D., et al. Comprehensive analysis of the naturally processed peptide repertoire: differences between HLA-A and B in the immunopeptidome. PLOS ONE 2015, 10:e0136417.
9. Mommen G.P., Frese C.K., Meiring H.D., van Gaans-van den Brink J., de Jong A.P., van Els C.A., Heck A.J. Expanding the detectable HLA peptide repertoire using electron-transfer/higher-energy collision dissociation (EThcD). Proc Natl Acad Sci U S A 2014, 111:4507-4512.
10. Bassani-Sternberg M., Pletscher-Frankild S., Jensen L.J., Mann M. Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol Cell Proteomics 2015, 14:658-673.
11. Bozzacco L., Yu H., Zebroski H.A., Dengjel J., Deng H., Mojsov S., Steinman R.M. Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J Proteome Res 2011, 10:5016-5030.
12. Collado J.A., Alvarez I., Ciudad M.T., Espinosa G., Canals F., Pujol-Borrell R., Carrascal M., Abian J., Jaraquemada D. Composition of the HLA-DR-associated human thymus peptidome. Eur J Immunol 2013, 43:2273-2282.
13. Marrack P., Ignatowicz L., Kappler J.W., Boymel J., Freed J.H. Comparison of peptides bound to spleen and thymus class II. J Exp Med 1993, 178:2173-2183.
14. Alvarez I., Collado J.A., Colobran R., Carrascal M., Ciudad M.T., Canals F., James E.A., Kwok W.W., Gartner M., Kyewski B., et al. Central T cell tolerance: identification of tissue-restricted autoantigens in the thymus HLA-DR peptidome. J Autoimmun 2015, 60:12-19.
15. Hansen K.C., D'Alessandro A., Clement C.C., Santambrogio L. Lymph formation, composition and circulation: a proteomics perspective. Int Immunol 2015, 27:219-227.
16. Clement C.C., Cannizzo E.S., Nastke M.D., Sahu R., Olszewski W., Miller N.E., Stern L.J., Santambrogio L. An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma. PLoS One 2010, 5:e9863.
17. Santambrogio L., Sato A.K., Carven G.J., Belyanskaya S.L., Strominger J.L., Stern L.J. Extracellular antigen processing and presentation by immature dendritic cells. Proc Natl Acad Sci U S A 1999, 96:15056-15061.
18. Amria S., Hajiaghamohseni L.M., Harbeson C., Zhao D., Goldstein O., Blum J.S., Haque A. HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition. Eur J Immunol 2008, 38:1961-1970.
19. Pathak S.S., Lich J.D., Blum J.S. Cutting edge: editing of recycling class II:peptide complexes by HLA-DM. J Immunol 2001, 167:632-635.
20. Villadangos J.A., Driessen C., Shi G.P., Chapman H.A., Ploegh H.L. Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM. EMBO J 2000, 19:882-891.
21. Santambrogio L., Sato A.K., Fischer F.R., Dorf M.E., Stern L.J. Abundant empty class II MHC molecules on the surface of immature dendritic cells. Proc Natl Acad Sci U S A 1999, 96:15050-15055.
22. Potolicchio I., Chitta S., Xu X., Fonseca D., Crisi G., Horejsi V., Strominger J.L., Stern L.J., Raposo G., Santambrogio L. Conformational variation of surface class II MHC proteins during myeloid dendritic cell differentiation accompanies structural changes in lysosomal MIIC. J Immunol 2005, 175:4935-4947.
23. Natarajan S.K., Assadi M., Sadegh-Nasseri S. Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides. J Immunol 1999, 162:4030-4036.
24. Rabinowitz J.D., Vrljic M., Kasson P.M., Liang M.N., Busch R., Boniface J.J., Davis M.M., McConnell H.M. Formation of a highly peptide-receptive state of class II MHC. Immunity 1998, 9:699-709.
25. Rupp B., Gunther S., Makhmoor T., Schlundt A., Dickhaut K., Gupta S., Choudhary I., Wiesmuller K.H., Jung G., Freund C., et al. Characterization of structural features controlling the receptiveness of empty class II MHC molecules. PLoS One 2011, 6:e18662.
26. Joshi R.V., Zarutskie J.A., Stern L.J. A three-step kinetic mechanism for peptide binding to MHC class II proteins. Biochemistry 2000, 39:3751-3762.
27. Schumacher T.N., Heemels M.T., Neefjes J.J., Kast W.M., Melief C.J., Ploegh H.L. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell 1990, 62:563-567.
28. Eisen H.N., Hou X.H., Shen C., Wang K., Tanguturi V.K., Smith C., Kozyrytska K., Nambiar L., McKinley C.A., Chen J., et al. Promiscuous binding of extracellular peptides to cell surface class I MHC protein. Proc Natl Acad Sci U S A 2012, 109:4580-4585.
29. Oluwole S.F., Jin M.X., Chowdhury N.C., Engelstad K., Ohajekwe O.A., Hardy M.A. Evidence for the role of host antigen-presenting cells in the induction of specific unresponsiveness to allografts by intrathymic inoculation of allopeptides. Transplant Proc 1995, 27:132-133.
30. Liblau R.S., Tisch R., Shokat K., Yang X., Dumont N., Goodnow C.C., McDevitt H.O. Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc Natl Acad Sci U S A 1996, 93:3031-3036.
31. Bonasio R., Scimone M.L., Schaerli P., Grabie N., Lichtman A.H., von Andrian U.H. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat Immunol 2006, 7:1092-1100.
32. Campbell J.D., Buckland K.F., McMillan S.J., Kearley J., Oldfield W.L., Stern L.J., Gronlund H., van Hage M., Reynolds C.J., Boyton R.J., et al. Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression. J Exp Med 2009, 206:1535-1547.
33. Chowdhury N.C., Jin M.X., Hardy M.A., Oluwole S.F. Donor-specific unresponsiveness to murine cardiac allografts induced by intrathymic-soluble alloantigens is dependent on alternate pathway of antigen presentation. J Surg Res 1995, 59:91-96.
34. Gallegos A.M., Bevan M.J. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med 2004, 200:1039-1049.
35. Goldschneider I., Cone R.E. A central role for peripheral dendritic cells in the induction of acquired thymic tolerance. Trends Immunol 2003, 24:77-81.
36. Oluwole S.F., Jin M.X., Chowdhury N.C., Engelstad K., Ohajekwe O.A., James T. Induction of peripheral tolerance by intrathymic inoculation of soluble alloantigens: evidence for the role of host antigen-presenting cells and suppressor cell mechanism. Cell Immunol 1995, 162:33-41.
37. Shimomura K., Hardy M.A., Oluwole S.F. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens. Transplantation 1995, 60:806-811.
38. Zal T., Volkmann A., Stockinger B. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J Exp Med 1994, 180:2089-2099.
39. Martin S., Bevan M.J. Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection. Eur J Immunol 1997, 27:2726-2736.
40. Idoyaga J., Fiorese C., Zbytnuik L., Lubkin A., Miller J., Malissen B., Mucida D., Merad M., Steinman R.M. Specialized role of migratory dendritic cells in peripheral tolerance induction. J Clin Invest 2013, 123:844-854.
41. Donskoy E., Goldschneider I. Two developmentally distinct populations of dendritic cells inhabit the adult mouse thymus: demonstration by differential importation of hematogenous precursors under steady state conditions. J Immunol 2003, 170:3514-3521.
42. Lovitch S.B., Walters J.J., Gross M.L., Unanue E.R. APCs present A beta(k)-derived peptides that are autoantigenic to type B T cells. J Immunol 2003, 170:4155-4160.
43. Cuervo A.M., Macian F. Autophagy and the immune function in aging. Curr Opin Immunol 2014, 29:97-104.
44. Hamasaki M., Shibutani S.T., Yoshimori T. Up-to-date membrane biogenesis in the autophagosome formation. Curr Opin Cell Biol 2013, 25:455-460.
45. Yang Z., Klionsky D.J. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010, 22:124-131.
46. Bernard A., Jin M., Xu Z., Klionsky D.J. A large-scale analysis of autophagy-related gene expression identifies new regulators of autophagy. Autophagy 2015, 11:2114-2122.
47. Schmid D., Pypaert M., Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007, 26:79-92.
48. Deretic V., Saitoh T., Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol 2013, 13:722-737.
49. Bradfute S.B., Castillo E.F., Arko-Mensah J., Chauhan S., Jiang S., Mandell M., Deretic V. Autophagy as an immune effector against tuberculosis. Curr Opin Microbiol 2013, 16:355-365.
50. Levine B. Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell 2005, 120:159-162.
51. Castillo E.F., Dekonenko A., Arko-Mensah J., Mandell M.A., Dupont N., Jiang S., Delgado-Vargas M., Timmins G.S., Bhattacharya D., Yang H., et al. Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation. Proc Natl Acad Sci U S A 2012, 109:E3168-E3176.
52. Watson R.O., Manzanillo P.S., Cox J.S. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 2012, 150:803-815.
53. Ravindran R., Khan N., Nakaya H.I., Li S., Loebbermann J., Maddur M.S., Park Y., Jones D.P., Chappert P., Davoust J., et al. Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation. Science 2014, 343:313-317.
54. Jagannath C., Lindsey D.R., Dhandayuthapani S., Xu Y., Hunter R.L., Eissa N.T. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 2009, 15:267-276.
55. Sahu R., Kaushik S., Clement C.C., Cannizzo E.S., Scharf B., Follenzi A., Potolicchio I., Nieves E., Cuervo A.M., Santambrogio L. Microautophagy of cytosolic proteins by late endosomes. Dev Cell 2011, 20:131-139.
56. Orenstein S.J., Cuervo A.M. Chaperone-mediated autophagy: molecular mechanisms and physiological relevance. Semin Cell Dev Biol 2010, 21:719-726.
57. Deffit S.N., Blum J.S. A central role for HSC70 in regulating antigen trafficking and MHC class II presentation. Mol Immunol 2015, 68:85-88.
58. Nedjic J., Aichinger M., Emmerich J., Mizushima N., Klein L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 2008, 455:396-400.
59. Zhou D., Li P., Lin Y., Lott J.M., Hislop A.D., Canaday D.H., Brutkiewicz R.R., Blum J.S. Lamp-2a facilitates MHC class II presentation of cytoplasmic antigens. Immunity 2005, 22:571-581.
60. Haque M.A., Hawes J.W., Blum J.S. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition. J Immunol 2001, 166:4543-4551.
61. Lovitch S.B., Pu Z., Unanue E.R. Amino-terminal flanking residues determine the conformation of a peptide-class II MHC complex. J Immunol 2006, 176:2958-2968.
62. Pu Z., Lovitch S.B., Bikoff E.K., Unanue E.R. T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM. Immunity 2004, 20:467-476.
63. Griffin J.P., Chu R., Harding C.V. Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms. J Immunol 1997, 158:1523-1532.
64. Nanda N.K., Bikoff E.K. DM peptide-editing function leads to immunodominance in CD4 T cell responses in vivo. J Immunol 2005, 175:6473-6480.
65. Vergelli M., Pinet V., Vogt A.B., Kalbus M., Malnati M., Riccio P., Long E.O., Martin R. HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing. Eur J Immunol 1997, 27:941-951.
66. Pinet V., Vergelli M., Martin R., Bakke O., Long E.O. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 1995, 375:603-606.
67. Nygard N.R., Giacoletto K.S., Bono C., Gorka J., Kompelli S., Schwartz B.D. Peptide binding to surface class II molecules is the major pathway of formation of immunogenic class II-peptide complexes for viable antigen presenting cells. J Immunol 1994, 152:1082-1093.
68. Kim A., Hartman I.Z., Poore B., Boronina T., Cole R.N., Song N., Ciudad M.T., Caspi R.R., Jaraquemada D., Sadegh-Nasseri S. Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources. Nat Commun 2014, 5:5369.
69. Sadegh-Nasseri S., Kim A. Exogenous antigens bind MHC class II first, and are processed by cathepsins later. Mol Immunol 2015, 68:81-84.
70. Bosch B., Berger A.C., Khandelwal S., Heipertz E.L., Scharf B., Santambrogio L., Roche P.A. Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells. J Biol Chem 2013, 288:24286-24292.
71. Spencer C.T., Dragovic S.M., Conant S.B., Gray J.J., Zheng M., Samir P., Niu X., Moutaftsi M., Van Kaer L., Sette A., et al. Sculpting MHC class II-restricted self and non-self peptidome by the class I Ag-processing machinery and its impact on Th-cell responses. Eur J Immunol 2013, 43:1162-1172.
72. Tewari M.K., Sinnathamby G., Rajagopal D., Eisenlohr L.C. A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent. Nat Immunol 2005, 6:287-294.
73. Adiko A.C., Babdor J., Gutierrez-Martinez E., Guermonprez P., Saveanu L. Intracellular transport routes for MHC I and their relevance for antigen cross-presentation. Front Immunol 2015, 6:335.
74. Segura E., Amigorena S. Cross-presentation in mouse and human dendritic cells. Adv Immunol 2015, 127:1-31.
75. Schuette V., Burgdorf S. The ins-and-outs of endosomal antigens for cross-presentation. Curr Opin Immunol 2014, 26:63-68.
76. Denzin L.K., Hammond C., Cresswell P. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med 1996, 184:2153-2165.
77. Denzin L.K., Cresswell P. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995, 82:155-165.
78. Kropshofer H., Arndt S.O., Moldenhauer G., Hammerling G.J., Vogt A.B. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 1997, 6:293-302.
79. Vogt A.B., Kropshofer H., Moldenhauer G., Hammerling G.J. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc Natl Acad Sci U S A 1996, 93:9724-9729.
80. Sloan V.S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E., Zaller D.M. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995, 375:802-806.
81. Zarutskie J.A., Busch R., Zavala-Ruiz Z., Rushe M., Mellins E.D., Stern L.J. The kinetic basis of peptide exchange catalysis by HLA-DM. Proc Natl Acad Sci U S A 2001, 98:12450-12455.
82. Pos W., Sethi D.K., Call M.J., Schulze M.S., Anders A.K., Pyrdol J., Wucherpfennig K.W. Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell 2012, 151:1557-1568.
83. Anders A.K., Call M.J., Schulze M.S., Fowler K.D., Schubert D.A., Seth N.P., Sundberg E.J., Wucherpfennig K.W. HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat Immunol 2011, 12:54-61.
84. Yin L., Maben Z.J., Becerra A., Stern L.J. Evaluating the role of HLA-DM in MHC class II-peptide association reactions. J Immunol 2015, 195:706-716.
85. Fallang L.E., Roh S., Holm A., Bergseng E., Yoon T., Fleckenstein B., Bandyopadhyay A., Mellins E.D., Sollid L.M. Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DM. J Immunol 2008, 181:5451-5461.
86. Belmares M.P., Busch R., Wucherpfennig K.W., McConnell H.M., Mellins E.D. Structural factors contributing to DM susceptibility of MHC class II/peptide complexes. J Immunol 2002, 169:5109-5117.
87. Zhou Z., Reyes-Vargas E., Escobar H., Rudd B., Rockwood A.L., Delgado J.C., He X., Jensen P.E. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides. Eur J Immunol 2015.
88. Weber D.A., Evavold B.D., Jensen P.E. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 1996, 274:618-620.
89. Lazarski C.A., Chaves F.A., Sant A.J. The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability. J Exp Med 2006, 203:1319-1328.
90. Nanda N.K., Sant A.J. DM determines the cryptic and immunodominant fate of T cell epitopes. J Exp Med 2000, 192:781-788.
91. Yin L., Trenh P., Guce A., Wieczorek M., Lange S., Sticht J., Jiang W., Bylsma M., Mellins E.D., Freund C., et al. Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide. J Biol Chem 2014, 289:23449-23464.
92. Yin L., Calvo-Calle J.M., Dominguez-Amorocho O., Stern L.J. HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives. J Immunol 2012, 189:3983-3994.
93. Tourne S., Miyazaki T., Wolf P., Ploegh H., Benoist C., Mathis D. Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes. Proc Natl Acad Sci U S A 1997, 94:9255-9260.
94. Martin W.D., Hicks G.G., Mendiratta S.K., Leva H.I., Ruley H.E., Van Kaer L. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 1996, 84:543-550.
95. Koonce C.H., Wutz G., Robertson E.J., Vogt A.B., Kropshofer H., Bikoff E.K. DM loss in k haplotype mice reveals isotype-specific chaperone requirements. J Immunol 2003, 170:3751-3761.
96. Mellins E., Smith L., Arp B., Cotner T., Celis E., Pious D. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature 1990, 343:71-74.
97. Lovitch S.B., Esparza T.J., Schweitzer G., Herzog J., Unanue E.R. Activation of type B T cells after protein immunization reveals novel pathways of in vivo presentation of peptides. J Immunol 2007, 178:122-133.
98. Strong B.S., Unanue E.R. Presentation of type B peptide-MHC complexes from hen egg white lysozyme by TLR ligands and type I IFNs independent of H2-DM regulation. J Immunol 2011, 187:2193-2201.
99. Kamala T., Nanda N.K. Protective response to Leishmania major in BALB/c mice requires antigen processing in the absence of DM. J Immunol 2009, 182:4882-4890.
100. Menges P.R., Jenks S.A., Bikoff E.K., Friedmann D.R., Knowlden Z.A., Sant A.J. An MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient mice. J Immunol 2008, 180:1619-1633.
101. Nepal R.M., Vesosky B., Turner J., Bryant P. DM, but not cathepsin L, is required to control an aerosol infection with Mycobacterium tuberculosis. J Leukoc Biol 2008, 84:1011-1018.
102. Miller M.A., Ganesan A.P., Luckashenak N., Mendonca M., Eisenlohr L.C. Endogenous antigen processing drives the primary CD4+ T cell response to influenza. Nat Med 2015, 21:1216-1222.
103. Depontieu F.R., Qian J., Zarling A.L., McMiller T.L., Salay T.M., Norris A., English A.M., Shabanowitz J., Engelhard V.H., Hunt D.F., et al. Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. Proc Natl Acad Sci U S A 2009, 106:12073-12078.
104. Engelhard V.H., Altrich-Vanlith M., Ostankovitch M., Zarling A.L. Post-translational modifications of naturally processed MHC-binding epitopes. Curr Opin Immunol 2006, 18:92-97.
105. Caron E., Espona L., Kowalewski D.J., Schuster H., Ternette N., Alpizar A., Schittenhelm R.B., Ramarathinam S.H., Lindestam Arlehamn C.S., Chiek Koh C., et al. An open-source computational and data resource to analyze digital maps of immunopeptidomes. Elife 2015, 4.
106. Croft N.P., Purcell A.W., Tscharke D.C. Quantifying epitope presentation using mass spectrometry. Mol Immunol 2015, 68:77-80.
107. Jiang W., Strohman M.J., Somasundaram S., Ayyangar S., Hou T., Wang N. Mellins ED: pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity. Sci Rep 2015, 5:17333.